CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells
- PMID: 25340755
- PMCID: PMC4207702
- DOI: 10.1371/journal.pone.0110731
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells
Abstract
The association between the host immune environment and the size of the HIV reservoir during effective antiretroviral therapy is not clear. Progress has also been limited by the lack of a well-accepted assay for quantifying HIV during therapy. We examined the association between multiple measurements of HIV and T cell activation (as defined by markers including CD38, HLA-DR, CCR5 and PD-1) in 30 antiretroviral-treated HIV-infected adults. We found a consistent association between the frequency of CD4+ and CD8+ T cells expressing HLA-DR and the frequency of resting CD4+ T cells containing HIV DNA. This study highlights the need to further examine this relationship and to better characterize the biology of markers commonly used in HIV studies. These results may also have implications for reactivation strategies.
Conflict of interest statement
Figures


References
-
- Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, et al. (2003) T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 187: 1534–1543. - PubMed
-
- Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, et al. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1: 1284–1290. - PubMed
-
- Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183–188. - PubMed
-
- Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350–354. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 AI080193/AI/NIAID NIH HHS/United States
- P30 MH062246/MH/NIMH NIH HHS/United States
- IK2 CX000520/CX/CSRD VA/United States
- UM1 AI069432/AI/NIAID NIH HHS/United States
- AI306214/AI/NIAID NIH HHS/United States
- 1U19AI096109/AI/NIAID NIH HHS/United States
- P30 AI027763/AI/NIAID NIH HHS/United States
- P30 AI036214/AI/NIAID NIH HHS/United States
- U19 AI096113/AI/NIAID NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- P30 MH62246/MH/NIMH NIH HHS/United States
- U19 AI096109/AI/NIAID NIH HHS/United States
- K24AI069994/AI/NIAID NIH HHS/United States
- K24 AT007827/AT/NCCIH NIH HHS/United States
- AI69432-S/AI/NIAID NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- K24 AI069994/AI/NIAID NIH HHS/United States
- P30 AI045008/AI/NIAID NIH HHS/United States
- R01AI087145/AI/NIAID NIH HHS/United States
- UL 1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI069432/AI/NIAID NIH HHS/United States
- AI74621/AI/NIAID NIH HHS/United States
- P01 AI074621/AI/NIAID NIH HHS/United States
- AI 080193/AI/NIAID NIH HHS/United States
- AI096113/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials